Search results for: Healthcare Systems
Filter search results
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes Advice on Medicinal Drug Development
4 October 2016, 11:00pm
…(Medicines and Healthcare products Regulatory Agency, MHRA, and European Medicines Agency, EMA). Despite these efforts HTA SA is not routinely integrated into the clinical development of new medicines and it…
OHE’s 2016 Annual Lecture with Dame Sally Davies: 10 Years of NIHR: Achievements and Challenges for the Next Decade
7 November 2016, 12:00am
…the IOM termed The Learning Healthcare System with the use of Big Data and an emphasis on gathering «real world evidence» by tracking NHS patients through observational studies and more…
International Drug Pricing Transparency
20 July 2020, 11:00pm
…essential for differential pricing, which in turn is viewed as necessary to balance patient access with continual innovation in drug development. Rising healthcare costs, fuelled by a changing political perspective…
The Value of a QALY Towards the End of Life and its Determinants: Experimental Evidence
20 June 2022, 11:00pm
…economics. The Value of a QALY towards the End of Life and its Determinants: Experimental Evidence OBJECTIVE End-of-life healthcare expenditure (HCE) is a substantial contributor to overall HCE. A widely…
Reminder: 2010 Lecture on US Health Reform
14 June 2010
…School of Medicine. Entitled ‘US Healthcare Reform: Monumental Health System Transformation or Fatally Flawed Compromise?’, his remarks will focus on the national health care legislation recently enacted in the US. Join us in…
EU Approval of Biosimilars
8 July 2010
…and summarises the remarks of Dr. Gopalan Narayanan of the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA). Biosimilar products in the European Union (EU) must go through a centralised procedure that licenses…
Part 1: 2010 Lecture on US Health Reform
20 July 2010
…Care and Outcomes Research at the School of Medicine. His presentation, ‘US Healthcare Reform: Monumental Health System Transformation or Fatally Flawed Compromise?’, is summarised in two blog posts. The first of…
Part 2: 2010 Lecture on US Health Reform
27 July 2010
…Stanford University’s Center for Health Policy and its Center for Primary Care and Outcomes Research at the School of Medicine. His presentation, ‘US Healthcare Reform: Monumental Health System Transformation or Fatally…
New OHE Commission on Competition in the NHS
14 February 2011
…Director and Deputy Chief Executive, St George’s Healthcare NHS Trust Anita Charlesworth, Chief Economist, The Nuffield Trust Nigel Edwards, Acting Chief Executive, NHS Confederation Julian Le Grand, Richard Titmuss Professor…